ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-OR070

Macrophage Mitophagy Deficiency Promotes Experimental and Human Kidney Fibrosis

Session Information

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Bhatia, Divya, Weill Cornell Medicine, New York, New York, United States
  • Chung, Kuei-Pin, Weill Cornell Medicine, New York, United States
  • Nakahira, Kiichi, Weill Cornell Medicine, New York, New York, United States
  • Patino, Edwin, Weill Cornell Medicine, New York, New York, United States
  • Rice, Michelle C., Weill Cornell Medicine, New York, New York, United States
  • Torres, Lisa K., Weill Cornell Medicine, New York, New York, United States
  • Muthukumar, Thangamani, Weill Cornell Medicine, New York, New York, United States
  • Choi, Augustine MK, Weill Cornell Medicine, New York, New York, United States
  • Akchurin, Oleh M., Weill Cornell Medicine, New York, New York, United States
  • Choi, Mary E., Weill Cornell Medicine, New York, New York, United States
Background

Mitochondrial quality control by mitophagy is critical for normal kidney function. We examined the role of PINK1, Mitofusin 2 (MFN2) and Parkin-mediated mitophagy in macrophage-induced kidney fibrosis, using experimental models of adenine diet (AD) or unilateral ureteral obstruction (UUO) and in human kidney fibrosis.

Methods

Kidney fibrosis in Pink1-/- or Prkn-/- mice was induced by AD or UUO. Role of MFN2 was studied using LysM-Cre+/-Mfn2fl/fl mice. Kidney tissues and primary macrophages were analyzed by flow cytometry, confocal and electron microscopy, qPCR, western blot, ELISA, and MitoStress test. PBMCs, plasma and kidney biopsies from patients with severe-CKD (GFR<30 ml/min/1.73m2,n=15) or biopsy-proven interstitial fibrosis & tubular atrophy (IFTA,n=6) were compared to patients with mild/moderate-CKD (GFR>30,n=8) or controls (no CKD,n=9).

Results

Expression of PINK1, MFN2, and Parkin was decreased in kidneys and renal macrophages after AD or UUO, as well as in TGF-β1-treated bone-marrow-derived macrophages (BMDMs), human renal macrophages, and THP-1-cells. Kidneys from Pink1-/- and Prkn-/- mice showed higher fibronectin, collagen-I, TGF-β1, galectin-3, and arginase-I after AD or UUO vs corresponding wild-type mice. Renal macrophages from AD-fed Pink1-/-mice had a higher number of abnormal mitochondria. Ly6ClowCD11b+, F4.80+CD206+ cells and CCL2 levels were increased in blood and kidneys from Pink1-/- and Prkn-/-mice after AD or UUO. Mitochondria from TGF-β1-treated Pink1-/- BMDMs showed lower respiration, higher mitochondrial ROS (mROS), and reduced colocalization with LC3. Mitophagy inhibition by Pink1-siRNA or Mdivi-1 resulted in decreased phosphorylation of downstream MFN2 and increased fibrotic response by human macrophages. LysM-Cre+/-Mfn2fl/fl macrophage mitochondria displayed lower recruitment of Parkin and mitophagy. Plasma, PBMCs, and kidney biopsies from patients with severe-CKD and IFTA showed higher CCL2 and mROS, and lower PINK1, MFN2 and PRKN expression.

Conclusion

Our study is the first to demonstrate that deficiency of PINK1/MFN2/PRKN-mediated mitophagy promotes macrophage-induced oxidative stress and fibrotic response, and is associated with human kidney fibrosis. Therapeutically targeting macrophage mitophagy pathway may protect against kidney fibrosis.

Funding

  • NIDDK Support